Introduction It is not always possible to differentiate infective from neoplastic brain lesions with conventional MR imaging. In this study, we assessed the utility of various perfusion indices in the differentiation of infective from neoplastic brain lesions. Methods A total of 103 patients with infective brain lesions (group I, n=26) and neoplastic brain lesions (highgrade glioma, HGG, group II, n=52; low-grade glioma, LGG, group III, n=25) underwent dynamic contrastenhanced MR imaging. The perfusion indices, including relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF), transfer coefficient (k trans ) and leakage (v e ), were calculated and their degree of correlation with immunohistologically obtained microvessel density (MVD) and vascular endothelial growth factor (VEGF) determined. The rCBV was corrected for the leakage effect. Discriminant analysis for rCBV, rCBF, k trans and v e was performed to predict the group membership of each case and post hoc analysis was performed to look for group differences. Results The rCBV, rCBF, k trans , v e , MVD and VEGF were significantly different (P<0.001) between the three groups. Discriminant analysis showed that rCBV predicted 73.1% of the infective lesions, 84.6% of the HGG and 72.0% of the LGG. The rCBF classified 86.5% of the HGG, 80.0% of the LGG and 65.4% of the infective lesions. The k trans discriminated 98.1% of the HGG, 76.0% of the LGG and 88.5% of the infective lesions correctly. The v e classified 98.1% of the HGG, 76.0% of the LGG and 84.6% the infective lesions. The rCBV was correlated significantly with MVD and VEGF, while the correlation between k trans and MVD was not significant. Conclusion Physiological perfusion indices such as k trans and v e appear to be useful in differentiating infective from neoplastic brain lesions. Adding these indices to the current imaging protocol is likely to improve tissue characterization of these focal brain mass lesions.
proton MR spectroscopy ( 1 H MRS), diffusion-weighted imaging (DWI) and perfusion-weighted imaging [1] [2] [3] [4] [5] [6] [7] have been used to differentiate brain infection from neoplasm; however, it is still problematic to separate these conditions. Combining techniques, such as DWI, 1 H MRS and MT imaging, has been shown to improved tissue characterization of these lesions [1] [2] [3] [4] [5] [6] [7] .
Angiogenesis plays a crucial role in the growth and aggressiveness of brain tumors [8] . It has also been reported to play a role in the infective pathology in response to the expression of various cytokines [9] . The most important cytokine in these two types of pathology is vascular endothelial growth factor (VEGF), which stimulates endothelial proliferation and increases transendothelial permeability [10, 11] . Other cytokines have also been reported in infective intracranial pathologies which directly or indirectly affect the endothelial permeability and integrity of the blood-brain barrier (BBB) [12] [13] [14] . The degree of endothelial permeability on MR imaging is typically represented by the endothelial permeability surface area product or the transfer coefficient (k trans ), which governs the leakage (v e ) of contrast agent from the vascular to the extravascular compartment [15] .
Perfusion-weighted imaging has been widely used for in vivo quantification of angiogenesis in various intracranial pathologies [5] [6] [7] [15] [16] [17] [18] [19] [20] . The widely accepted technique used for perfusion imaging is the dynamic susceptibility contrast-enhanced technique (DSC) which is based on the T2-or T2*-weighted susceptibility effect [5] [6] [7] [16] [17] [18] . This technique has been widely used for the quantification of the hemodynamic perfusion indices cerebral blood volume (CBV) and cerebral blood flow (CBF) [5] [6] [7] [16] [17] [18] . In the presence of a disrupted BBB, the DSC technique is unable to provide an accurate measurement of homodynamic parameters due to the T1 shine-through effect of the leaky contrast agent [15, 19] . The T1-based dynamic contrast-enhanced (DCE) perfusion technique has been used for the quantification of physiological parameters (k trans and v e ) [15, 19, 20] . Recently, the DCE technique with modification has been able to provide measurements of hemodynamic parameters, and by applying a pharmacokinetic model it is possible to correct the CBV if a disrupted BBB is present [20] .
The DSC-derived CBV has been used to differentiate infective from neoplastic lesions but with conflicting results. Some have reported similar patterns of rCBV in these two lesions while others have found a significant decrease in rCBV in infective lesions compared to neoplastic lesions [5] [6] [7] .
The aim of this study was to assess the usefulness of DCE-derived perfusion indices (rCBV, rCBF, k trans and v e ) in characterizing two different brain pathologies, i.e. infective vs. neoplastic lesions. The degree of correlation between immunohistochemically obtained levels of VEGF and k trans was determined to elucidate the impact of VEGF on BBB permeability.
Materials and methods

Patients
A total of 103 untreated consecutive patients with different brain pathologies were included in this study. The patients were divided into three groups. Group 1 comprised those with an infective lesion (mean±SD age 26.6±9.31 years, 11 male and 15 female) including brain tuberculoma (n=18), brain abscess (n=6) and fungal granuloma (n=2). Groups 2 and 3 comprised those with a neoplastic lesion, either highgrade glioma (HGG, group 2, age 47.5±11.3 years, 41 male and 11 female) or low-grade glioma (LGG, group 3, age 36.28±11.20 years, 16 male and 9 female). Grades III and IV gliomas were considered HGG and grades I and II gliomas were considered LGG. The final grading of a glioma was confirmed only after histopathology. The grading of the gliomas was based on the WHO classification [21] .
Patients who presented with signs and symptoms of a mass lesion and/or seizures were initially identified on conventional MR imaging and these formed the inclusion criteria for the study. The initial diagnosis of tuberculoma was based on the characteristic imaging features on MT T1-weighted MR imaging and/or 1 H MRS and these were the inclusion criteria for the study [1, 2] . As part of the clinical management, all patients with tuberculoma underwent surgery following imaging.
The initial diagnosis of brain abscess was based on its characteristic features on conventional MRI, DWI and in vivo 1 H MRS [3, 4] . The final diagnosis of brain abscess was confirmed at surgery as well as by the results of culture of aspirated pus. The reason for performing surgery in brain abscess was poor clinical condition even after aspiration of pus (n=6). The diagnosis of fungal granuloma (n=2) was only confirmed after histopathology. The reason for surgery in fungal granuloma (n=2) was uncertainty regarding the diagnosis. All these patients were tested for serum HIV and were found to be negative. None of the patients was receiving treatment with a steroid.
Imaging protocol
Following conventional MR imaging, all patients underwent DCE MR imaging using a bird-cage quadrature head coil on a 1.5-T GE scanner (Signa, Lx Echospeed plus; General Electric Medical Systems, Milwaukee, WI). All patients gave their informed consent prior to DCE MR imaging. The institutional ethics as well as the research committees approved the study protocol. Baseline T2-weighted (TR/TE 4,900/85 ms, NEX 2), T1-weighted (TR/TE 1,000/14 ms, NEX 1), and T1-weighted MT (TR/ TE 1,000/14 ms, NEX 1, flip angle 65°, off-resonance pulse with frequency offset 1200 kHz) imaging was performed in the axial plane with a 5-mm slice thickness, 256×256 matrix, and 240×240 mm field of view (FOV), with no slice gap.
DCE imaging was performed using a three-dimensional spoiled gradient recalled echo (3D-SPGR) sequence (TR/ TE 5.0/1.4 ms, flip angle 15°, FOV 360×270 mm, slice thickness 6 mm, matrix size 128×128, NEX 0.5, number of phases 32). At the fourth acquisition, gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA, Omniscan, Amersham Health, Oslo, Norway) 0.2 mmol/kg body weight was administered intravenously using a power injector (Optistar MR, Liebel-Flarsheim/Mallinckrodt, Cincinnati, OH) at a rate of 5 ml/s, followed by a bolus injection of 30 ml saline flush. A series of 384 images at 32 time points in 12 slices were acquired with a temporal resolution of approximately 5.25 s for each time point. The 12 slices were sufficient to completely cover the entire lesion including the normal brain parenchyma in all patients studied.
Prior to 3D SPGR, fast spin echo (FSE) T1-weighted (TR/TE 375/9.4 ms, FOV 360×270 mm, slice thickness 6 mm, matrix size 256×256, NEX 1) and fast double spin echo proton density-weighted (PD-weighted) and T2-w e i gh t e d ( T R / T E 1/ T E 2 3 50 0/ 25 / 85 m s , FO V 360×270 mm, slice thickness 6 mm, matrix size 256×256, NEX 1) imaging was performed for the same slice position to quantify voxel-wise the precontrast tissue parameter T10 [20] .
Data processing
The data were processed using in-house developed Javabased perfusion software [20] . Images were registered for voxel-wise analysis [22] . For absolute pharmacokinetic analysis the value of the precontrast tissue parameter T10 needs to be known. The voxel-wise tissue T10 value was calculated from fast spin echo T1-, T2-and PD-weighted images [20] . The absolute tissue T10 value was used to generate concentration-time curves from signal intensitytime curves obtained from the 3D-SPGR sequence [20] . The concentration-time curves were analyzed for calculation of CBV and CBF [20] . Physiological maps (k trans and v e ) were generated by fitting the concentration-time curves to the pharmacokinetic model [20] . Corrected CBV maps were generated by removing the leakage effect of the disrupted BBB [20] . In this study CBV was calculated from corrected CBV maps and in the remainder of the text CBV refers to the corrected CBV.
Image analysis
Perfusion indices (rCBV, rCBF, k trans and v e ) were calculated by placing the region of interest (ROI) on the whole lesion of each slice. The shape and size of the ROI was guided by the lesion size and shape. The T1-and T2-weighted images were coregistered with physiological maps for accurate placement of the ROI.
Contrast agent uptake curves
The change in T1 relaxation after administration of Gd-DTPA was used to calculate the contrast agent concentration for the ROI selected on color-coded v e maps in infective as well as neoplastic lesions (HGG and LGG). The ROI was selected on all color-coded v e maps showing the lesion. The average contrast agent concentration for all ROIs at each time point in each patient were calculated to generate a contrast uptake curve using 95% confidence intervals (CI) of the mean, separately for infective lesions (n=26), HGG (n=52) and LGG (n=25).
Scatter plots
The relationship between k trans and v e and between rCBV and rCBF for infective lesions, HGG and LGG were evaluated in the form of scatter plots.
Histopathology
Tissue preparation All excised lesions were fixed in 10% buffered formalin and embedded in paraffin. Whole specimens were blocked and sections of thickness 6 μm were taken for immunohistochemical analysis.
Immunohistochemistry The sections were dewaxed in xylene, dehydrated through a graded series of alcohol concentrations and washed in Tris buffer (pH 7.2). For antigen retrieval, the sections were immersed in citrate buffer (pH 6.2) at 90°C for 1 h in a water-bath and then incubated with 3% hydrogen peroxide in methanol for 15 min to block endogenous peroxidase activity. After washing twice in Tris buffer, sections were incubated for 3-4 h at room temperature, separately with polyclonal antibody against human VEGF (A-20; Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:100, and monoclonal antibody to CD34 antigen (Dakopatts, Denmark) at a dilution of 1:50. Following washing in Tris buffer, sections were sequentially incubated with biotinylated link secondary antibody and peroxidase-labeled streptavidin (LSAB; Dakopatts, Denmark) for 30 min in each. The sections were again washed twice in Tris buffer and incubated with the chromogen diaminobenzidinetetrahydrochloride (DAB) substrate and were then counterstained in hematoxylin. The sections were mounted in DPX mountant. Parallel control slides were run with all batches including positive and negative controls.
Quantitative measurement of MVD and VEGF expression For evaluation and measurement of CD34 immunoreactive vessels of tissue vasculature, each CD34-immunostained slide was digitized with the ×40 objective of a Canon Power Shot G5 camera and the captured images were analyzed morphometrically using the Biovis image analysis system (Expert Vision, Mumbai, India). To determine the MVD, all discrete, positively immunostained endothelial clusters with lumina were counted in ten ×40 fields under a light microscope (Carl Ziess Axiolab), indicating the highest MVD in whole sections of each lesion. Large vessels with a muscular wall were excluded from the analysis. MVD was reported as the number of vessels per high-power field (HPF). Similarly, VEGF expression was determined for ten HPFs (×40) using the same image analysis system and the percentage of cells showing positive staining for VEGF determined. The average value of MVD and VEGF for ten fields was taken for statistical analysis. An experienced pathologist blinded to the MRI data carried out all the neuropathological investigations.
Statistical analysis
Group-wise descriptive statistics were determined and analysis of variance (ANOVA) was performed using the post hoc test. The post hoc test was also carried out to determine the significance of differences in the various perfusion indices among the infective lesions. For this analysis the number of measurements in each slice was considered as there were only two patients with fungal granuloma. The degree of correlation among perfusion indices and immunohistochemically obtained MVD and VEGF was determined in terms of the Pearson correlation coefficient. A linear discriminant analysis was performed to identify factors capable of group classification. The discriminant analysis was carried out for rCBV, rCBF, k trans and v e . The analyses were performed using SPSS version 12.0 (SPSS, Chicago, IL).
Results
The mean values of the perfusion indices (rCBV, rCBF, k trans and v e ) and immunohistochemically obtained MVD and VEGF in infective lesions (Figs. 1, 2 and 3) , HGG (Fig. 4) and LGG (Fig. 5 ) are shown in Table 1 . All infective lesions, and grade III and grade IV gliomas showed positive immunostaining for VEGF while only 12 ) and v e (0.63) maps show the high penetration of contrast agent across the BBB into the extracellular extravascular space. h CD34 immunostaining highlights microvessels in granulomatous areas of the lesion (arrow, LSAB ×125 ×digital magnification). i VEGF staining is seen in the cytoplasm of giant cells, macrophages and fibroblasts (LSAB ×525 ×digital magnification) Fig. 2 Right temporal tuberculoma in a 29-year-old female patient. a-c The lesion appears hypointense on the T2-weighted image (a) and isointense with a slightly hyperintense rim on the T1-weighted image (b) with increased prominence of the rim on the MT T1-weighted image (c) Table 2 ). The rCBF correctly classified 86.5% of the HGG, 80.0% of the LGG and 65.4% the infective lesions ( Table 2 ). It misdiagnosed 13.5% of the HGG and 20.0% of the LGG as infective lesions ( Table 2 ). The parameter k trans classified 98.1% of the HGG, 76.0% of the LGG and 88.5% the infective lesions correctly ( Table 2) . It did not misdiagnose HGG or LGG as infective lesions ( Table 2 ). The parameter v e classified 98.1% of the HGG, 76.0% the LGG and 84.6% of the infective lesions correctly, but misdiagnosed 1.9% of the HGG as infective lesions. The discriminant variables together accounted for 100% of the variance in the model.
Contrast agent uptake curves
The contrast agent uptake curves at 95% CI of the mean clearly showed highest uptake of contrast agent in the interstitial space of infective lesions compared to HGG and LGG (Fig. 6 ). There was no marked difference in contrast agent uptake between infective lesions and HGG at initial time points (up to 12 time points), while at later time points uptake increased considerably in infective lesions. There was a marked difference in contrast agent uptake between HGG and LGG at early time points (up to 17 time points), but the difference decreased at later time points.
Scatter plots
A scatter plot of average k trans vs. v e values is shown in Fig. 7 . The k trans and v e values of five infective lesions and those of some LGG overlapped with those of HGG. Cut-off values of 1.5 min −1 for k trans and 0.52 for v e were derived to differentiate infective lesions from neoplastic lesions based on the scatter plot. The scatter plot of rCBV vs. rCBF (Fig. 7) shows overlap between infective lesions and LGG and HGG. No cut-off values for rCBV and rCBF could be derived to differentiate infective lesions from neoplastic lesions.
Discussion
The present study showed significantly lower values of hemodynamic indices (rCBV and rCBF) in infective lesions than in HGG, while the values were significantly higher in infective lesions than in LGG. The higher rCBV in HGG may be explained by the increased expression of VEGF responsible for the higher angiogenesis (MVD) and in turn rCBV. In LGG the expression of VEGF was lower than in infective lesions and this may have resulted in lower angiogenesis (MVD) and in turn decreased rCBV.
Significantly higher values of k trans in infective lesions suggests higher BBB permeability than in neoplastic lesions. Opening of the BBB in brain tumors primarily depends upon the secretion of VEGF [10, 23] . It has been reported that VEGF has a short-term early effect in BBB opening, while in the long term it stimulates angiogenesis [15, 24] . In the current study, a weak correlation between k trans and VEGF also suggests no role of VEGF in the longterm opening of the BBB. The major role of VEGF in neoangiogenesis is shown by the strong positive correlation among rCBV, MVD and VEGF both in infective and neoplastic lesions.
A role of vasoactive molecules such as bradykinin (BK) and leukotriene C4 (LTC4) in selectively increasing the permeability of brain tumor capillaries has been reported [25] [26] [27] . Overexpression of bradykinin type 2 receptor (B2R) on glioma cells is responsible for the increased BKmediated BBB permeability [25, 27] . Two major potassium channels, calcium-dependent potassium channels and ATPsensitive potassium channels, are overexpressed in brain tumor capillaries and tumor cells which play an important role in the regulation of BBB permeability [25] . All these factors are responsible for the long-term permeability of the Fig. 6 Contrast agent uptake curves. The highest uptake of contrast agent is seen in infective lesions followed by HGG and LGG. There is not much difference in contrast agent uptake at initial time points (up to 12 time points) between infective lesions and HGG, while at later time points uptake increases considerably in infective lesions. There is a marked difference in contrast agent uptake between HGG and LGG at early time points (up to 17 time points), but the difference decreases at later time points due to accumulation of contrast agent in the interstitial space of LGG BBB in brain tumors. Our findings suggest that higher expression of these factors may be responsible for the difference in the physiological indices between HGG and LGG.
In infective brain lesions, a number of cytokines including VEGF are secreted in response to the primary immunity against pathogens [11] [12] [13] [14] . These cytokines in turn upregulate the expression of various cell adhesion molecules (CAMs) [12] [13] [14] which are responsible for extravasation of inflammatory molecules and leukocytes through opening of the BBB by widening the endothelial gaps [13, 14, 28] . The intracellular CAM and vascular CAM and its ligands (lymphocyte function associated antigen-1 and very late antigen-4) are expressed on the surface of endothelial and leukocyte cells and play an important role in opening the BBB during intracranial infection [13, 14] . Maenpaa et al. [29] have reported weak expression of these CAMs on capillaries and large blood vessels in some HGG. The extent of opening of the BBB mediated by CAMs and their ligands in intracranial infection can be predicted by the fact that it allows the passage of leukocytes to the site of infection for phagocytic activity [13, 14, 28] . However, in brain tumors only BK can increase the permeability (by up to 12-fold) allowing the transport of molecules ranging in mass from 100 to 70,000 Da which are much smaller than leukocytes [27] . We hypothesize that there is a larger opening of the BBB in infective lesions than in glioma which is responsible for the significantly higher values of k trans and v e in intracranial infections and is well supported by the molecular mechanisms described above governing BBB disruption in both conditions. No significant difference in both perfusion indices and immunohistochemically obtained parameters among infective lesions suggests the same level of angiogenesis as well as BBB disruption. The significant positive correlation between v e and k trans suggests that v e is primarily governed by k trans . The significantly higher values of v e in intracranial infections suggest the presence of larger extracellular and extravascular space (EES) in which pooling of contrast agent occurred, compared to the neoplastic lesions.
The rCBV has been widely used for grading and monitoring therapeutic response in gliomas [17, 18, 30] . The parameter k trans has also been used in grading glioma, but with conflicting results [31] [32] [33] . In this study, both the rCBV and rCBF classified lower percentages of the infective lesions than k trans and v e , and also misdiagnosed a fair number of HGG and LGG as infective lesions, suggesting that these two perfusion indices could not be used for the reliable differentiation of infective from neoplastic lesions. The parameter k trans correctly classified 88.5% of infective lesions without any overlap with gliomas ( Table 2 ), suggesting that k trans could be used specifically for differentiating infective from neoplastic lesions. However, v e classified 84.6% of infective lesions correctly, but misdiagnosed 1.9% of HGG as infective lesions. This is because k trans gives information only about the integrity of the BBB which is different between HGG and LGG, while v e (indicated by the concentration of contrast agent in the EES) will depend on the scanning time. In contrast, k trans is not be affected by the scanning time, but v e may increase with scanning time for the same BBB status. Hence, a lesion with decreased permeability can also show an increased v e depending on the scanning time and size of the EES. This could be explained by the contrast agent uptake curves which showed that contrast agent uptake was lower in LGG than in HGG at early time points but increased with time (Fig. 6 ). High uptake of contrast agent in intracranial infection as shown in the contrast agent uptake curve (Fig. 6 ) also indicates the increased v e in the current study. The scatter plot of rCBV vs. rCBF (Fig. 7) showed overlap between these two parameters for infective and neoplastic lesions and these parameters cannot be used to differentiate infective from neoplastic lesions. However, the scatter plot of k trans vs. v e (Fig. 7) showed that most of the infective lesions had a k trans value more than 1.5 min −1 and a v e value more than 0.52. Hence, these values could be used as cut-off values to differentiate infective from neoplastic brain lesions.
No image-guided correlation of the immunohistopathology with perfusion indices was performed and this may be a limitation of the present study. We suggest that imageguided analysis would improve the correlation between rCBV, MVD and VEGF.
We conclude that the physiological perfusion indices k trans and v e appear to be useful differentiating infective from neoplastic brain lesions. Adding these indices to the current imaging protocol would be likely to improve tissue characterization of these focal brain mass lesions.
